Search Results - "Platinum Compounds adverse effects"

Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.

Authors: Ferrara, R. Imbimbo, M. Malouf, R. et al.

Subject Terms: Aged, Antibodies, Monoclonal/therapeutic use, Monoclonal, Humanized/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, B7-H1 Antigen/metabolism, Bevacizumab/adverse effects, Bevacizumab/therapeutic use, Bias, Carcinoma, Non-Small-Cell Lung/drug therapy, Non-Small-Cell Lung/metabolism, Non-Small-Cell Lung/mortality, Non-Small-Cell Lung/pathology, Female, Humans, Immune Checkpoint Inhibitors/adverse effects, Immune Checkpoint Inhibitors/therapeutic use, Lung Neoplasms/drug therapy, Lung Neoplasms/mortality, Lung Neoplasms/pathology, Male, Middle Aged, Nivolumab/adverse effects, Nivolumab/therapeutic use, Platinum Compounds/adverse effects, Platinum Compounds/therapeutic use, Progression-Free Survival

Relation: Cochrane Database of Systematic Reviews; https://iris.unil.ch/handle/iris/98047; serval:BIB_4269DE5E4AA2; 000646037100031

Availability: https://iris.unil.ch/handle/iris/98047
https://doi.org/10.1002/14651858.CD013257.pub3

Anti-tumour activity of platinum compounds in advanced prostate cancer—a systematic literature review

Authors: Hager, S Ackermann, C J Joerger, M et al.

Source: Hager, S, Ackermann, C J, Joerger, M, Gillessen, S & Omlin, A 2016, 'Anti-tumour activity of platinum compounds in advanced prostate cancer-a systematic literature review', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 27, no. 6, pp. 975-84. https://doi.org/10.1093/annonc/mdw156

Subject Terms: Male, Taxoids/adverse effects, Platinum Compounds, Docetaxel, Radium/therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Nitriles, Phenylthiohydantoin, Platinum Compounds/adverse effects, Androgen Receptor Antagonists, Humans, Prostatic Neoplasms, Castration-Resistant/drug therapy, Clinical Trials as Topic, Phenylthiohydantoin/adverse effects, Combined Modality Therapy, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre, Androgen Receptor Antagonists/adverse effects, 3. Good health, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Cisplatin/adverse effects, Benzamides, Taxoids, Cisplatin, Radium

Access URL: https://pubmed.ncbi.nlm.nih.gov/27052650
https://www.sciencedirect.com/science/article/pii/S0923753419356601
http://annonc.oxfordjournals.org/content/27/6/975.full.pdf
https://www.research.manchester.ac.uk/portal/en/publications/antitumour-activity-of-platinum-compounds-in-advanced-prostate-cancera-systematic-literature-review(3d2dcec0-c92b-4f1b-a352-31dd491bc100).html
https://academic.oup.com/annonc/article/27/6/975/1741865
https://paperity.org/p/76191819/anti-tumour-activity-of-platinum-compounds-in-advanced-prostate-cancer-a-systematic
https://pubmed.ncbi.nlm.nih.gov/27052650/

Chemotherapy-induced peripheral neuropathy and physiotherapy / Cellegift-indusert perifer polynevropati og fysioterapi

Authors: Haugen, Gro S Nesvold, Inger-Lise Sagen, Åse

Source: Fysioterapeuten. 80(4):26